E-LIB Suche - Ergebnisse für: Samar Farouk Ahmed

1

Substantial and comparable suppression of disease activity ..:

Alroughani, Raed ; Al-Hashel, Jasem ; Ahmed, Samar Farouk
Clinical Neurology and Neurosurgery. 240 (2024) - p. 108249 , 2024

Link: https://doi.org/10.1016/..

2

Ocrelizumab for Pediatric Relapsing Multiple Sclerosis:

Alroughani, Raed ; Almojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105269 , 2023

Link: https://doi.org/10.1016/..

3

Pediatric Onset Multiple Sclerosis in Kuwait:

Alroughani, Raed ; Almojel, Malak ; Qasem, Dalal..
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105270 , 2023

Link: https://doi.org/10.1016/..

4

Real world study of ocrelizumab in multiple sclerosis: Kuwa..:

Alroughani, Raed ; AlMojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders. 79 (2023) - p. 104941 , 2023

Link: https://doi.org/10.1016/..

5

Early Initiation of High Efficacy Disease Modifying Therapi..:

Alroughani, Raed ; Al-Hashel, Jasem ; Ahmed, Samar Farouk
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105326 , 2023

Link: https://doi.org/10.1016/..

6

A real-life study of alemtuzumab in persons with multiple s..:

Alroughani, Raed ; AlMojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders. 74 (2023) - p. 104712 , 2023

Link: https://doi.org/10.1016/..

7

A prospective observational longitudinal study with a two-y..:

Al-Hashel, Jasem ; Ahmed, Samar Farouk ; AlMojel, Malak.
Clinical Neurology and Neurosurgery. 232 (2023) - p. 107885 , 2023

Link: https://doi.org/10.1016/..

8

Ocrelizumab and Cladribine Had Similar EDSS Stability in Pa..:

Alroughani, Raed ; Al-Hashel, Jasem ; Alshwaf, Fatmha...
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105330 , 2023

Link: https://doi.org/10.1016/..

9

Ten Years Natural History of Multiple Sclerosis in Kuwait P..:

Alroughani, Raed ; Al-Hashel, Jasem ; Almojel, Malak.
Multiple Sclerosis and Related Disorders. 71 (2023) - p. 104261 , 2023

Link: https://doi.org/10.1016/..

10

Real World Study of Ocrelizumab in Multiple Sclerosis: Kuwa..:

Alroughani, Raed ; Almojel, Malak ; Al-Hashel, Jasem.
Multiple Sclerosis and Related Disorders. 80 (2023) - p. 105327 , 2023

Link: https://doi.org/10.1016/..

11

Real-Life Study with Alemtuzumab, Kuwait Experience:

Alroughani, Raed ; Al-Hashel, Jasem ; Almojel, Malak.
Multiple Sclerosis and Related Disorders. 71 (2023) - p. 104365 , 2023

Link: https://doi.org/10.1016/..

12

Real-Life Study with Cladribine: Kuwait Experience:

Ahmed, Samar Farouk ; Al-Hashel, Jasem ; Alroughani, Raed
Multiple Sclerosis and Related Disorders. 71 (2023) - p. 104350 , 2023

Link: https://doi.org/10.1016/..

13

Economic Analysis for Introduction of Cladribine Tablets as..:

Alroughani, Raed ; Ahmed, Samar Farouk ; Abokoura, Amr...
Multiple Sclerosis and Related Disorders. 59 (2022) - p. 103627 , 2022

Link: https://doi.org/10.1016/..

14

Incidence, Severity, Outcomes, and Risk Factors of COVID-19..:

Alroughani, Raed ; Inshasi, Jihad Said ; Al-Hashel, Jasem...
Multiple Sclerosis and Related Disorders. 59 (2022) - p. 103579 , 2022

Link: https://doi.org/10.1016/..

15

Association of Multiple Sclerosis and COVID-19 Infection: A..:

Ismail, Ismail Ibrahim ; Al-Hashel, Jasem ; Alroughani, Raed.
Multiple Sclerosis and Related Disorders. 59 (2022) - p. 103608 , 2022

Link: https://doi.org/10.1016/..